View in EDS PDF Full Text

Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice.

Saved in:
Bibliographic Details
Title: Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice.
Authors: Conde E; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.; Sorbonne University, ED394, Paris, France.; Neovacs SA, Paris, France., Bertrand R; Neovacs SA, Paris, France., Balbino B; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.; Sorbonne University, ED394, Paris, France., Bonnefoy J; Neovacs SA, Paris, France., Stackowicz J; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.; Sorbonne University, ED394, Paris, France., Caillot N; Neovacs SA, Paris, France., Colaone F; Neovacs SA, Paris, France., Hamdi S; Neovacs SA, Paris, France., Houmadi R; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Loste A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Kamphuis JBJ; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Huetz F; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France., Guilleminault L; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.; Department of respiratory medicine, Toulouse University Hospital, Faculty of Medicine, Toulouse, France., Gaudenzio N; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Mougel A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Hardy D; Institut Pasteur, Experimental Neuropathology Unit, Paris, France., Snouwaert JN; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Koller BH; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Serra V; Neovacs SA, Paris, France., Bruhns P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France., Grouard-Vogel G; Neovacs SA, Paris, France., Reber LL; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France. laurent.reber@inserm.fr.; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France. laurent.reber@inserm.fr.
Source: Nature communications [Nat Commun] 2021 May 11; Vol. 12 (1), pp. 2574. Date of Electronic Publication: 2021 May 11.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33976140
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Conde+E%22">Conde E</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.; Sorbonne University, ED394, Paris, France.; Neovacs SA, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bertrand+R%22">Bertrand R</searchLink>; Neovacs SA, Paris, France.<br /><searchLink fieldCode="AU" term="%22Balbino+B%22">Balbino B</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.; Sorbonne University, ED394, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bonnefoy+J%22">Bonnefoy J</searchLink>; Neovacs SA, Paris, France.<br /><searchLink fieldCode="AU" term="%22Stackowicz+J%22">Stackowicz J</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.; Sorbonne University, ED394, Paris, France.<br /><searchLink fieldCode="AU" term="%22Caillot+N%22">Caillot N</searchLink>; Neovacs SA, Paris, France.<br /><searchLink fieldCode="AU" term="%22Colaone+F%22">Colaone F</searchLink>; Neovacs SA, Paris, France.<br /><searchLink fieldCode="AU" term="%22Hamdi+S%22">Hamdi S</searchLink>; Neovacs SA, Paris, France.<br /><searchLink fieldCode="AU" term="%22Houmadi+R%22">Houmadi R</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Loste+A%22">Loste A</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Kamphuis+JBJ%22">Kamphuis JBJ</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Huetz+F%22">Huetz F</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Guilleminault+L%22">Guilleminault L</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.; Department of respiratory medicine, Toulouse University Hospital, Faculty of Medicine, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Gaudenzio+N%22">Gaudenzio N</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Mougel+A%22">Mougel A</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Hardy+D%22">Hardy D</searchLink>; Institut Pasteur, Experimental Neuropathology Unit, Paris, France.<br /><searchLink fieldCode="AU" term="%22Snouwaert+JN%22">Snouwaert JN</searchLink>; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Koller+BH%22">Koller BH</searchLink>; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Serra+V%22">Serra V</searchLink>; Neovacs SA, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bruhns+P%22">Bruhns P</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Grouard-Vogel+G%22">Grouard-Vogel G</searchLink>; Neovacs SA, Paris, France.<br /><searchLink fieldCode="AU" term="%22Reber+LL%22">Reber LL</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France. laurent.reber@inserm.fr.; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France. laurent.reber@inserm.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2021 May 11; Vol. 12 (1), pp. 2574. <i>Date of Electronic Publication: </i>2021 May 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33976140
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-021-22834-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2574
    Titles:
      – TitleFull: Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Conde E
      – PersonEntity:
          Name:
            NameFull: Bertrand R
      – PersonEntity:
          Name:
            NameFull: Balbino B
      – PersonEntity:
          Name:
            NameFull: Bonnefoy J
      – PersonEntity:
          Name:
            NameFull: Stackowicz J
      – PersonEntity:
          Name:
            NameFull: Caillot N
      – PersonEntity:
          Name:
            NameFull: Colaone F
      – PersonEntity:
          Name:
            NameFull: Hamdi S
      – PersonEntity:
          Name:
            NameFull: Houmadi R
      – PersonEntity:
          Name:
            NameFull: Loste A
      – PersonEntity:
          Name:
            NameFull: Kamphuis JBJ
      – PersonEntity:
          Name:
            NameFull: Huetz F
      – PersonEntity:
          Name:
            NameFull: Guilleminault L
      – PersonEntity:
          Name:
            NameFull: Gaudenzio N
      – PersonEntity:
          Name:
            NameFull: Mougel A
      – PersonEntity:
          Name:
            NameFull: Hardy D
      – PersonEntity:
          Name:
            NameFull: Snouwaert JN
      – PersonEntity:
          Name:
            NameFull: Koller BH
      – PersonEntity:
          Name:
            NameFull: Serra V
      – PersonEntity:
          Name:
            NameFull: Bruhns P
      – PersonEntity:
          Name:
            NameFull: Grouard-Vogel G
      – PersonEntity:
          Name:
            NameFull: Reber LL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 05
              Text: 2021 May 11
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1